Nabeel Khan

2.6k total citations
93 papers, 1.7k citations indexed

About

Nabeel Khan is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nabeel Khan has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 43 papers in Epidemiology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nabeel Khan's work include Inflammatory Bowel Disease (45 papers), Microscopic Colitis (30 papers) and COVID-19 Clinical Research Studies (10 papers). Nabeel Khan is often cited by papers focused on Inflammatory Bowel Disease (45 papers), Microscopic Colitis (30 papers) and COVID-19 Clinical Research Studies (10 papers). Nabeel Khan collaborates with scholars based in United States, United Kingdom and Pakistan. Nabeel Khan's co-authors include Ali Abbas, Chinmay Trivedi, Yu‐Xiao Yang, Dhruvan Patel, Gary R. Lichtenstein, Lydia Bazzano, James D. Lewis, Yash Shah, Nadim Mahmud and Edward V. Loftus and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Nabeel Khan

87 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabeel Khan United States 23 950 813 334 256 213 93 1.7k
Julien Kirchgesner France 21 1.2k 1.3× 923 1.1× 506 1.5× 260 1.0× 342 1.6× 59 1.9k
Amar R. Deshpande United States 22 1.2k 1.3× 973 1.2× 549 1.6× 182 0.7× 321 1.5× 93 2.2k
Frank I. Scott United States 24 607 0.6× 523 0.6× 547 1.6× 94 0.4× 211 1.0× 118 1.8k
Susana Lopes Portugal 25 577 0.6× 656 0.8× 518 1.6× 167 0.7× 270 1.3× 128 1.8k
Ida Vind Denmark 24 1.7k 1.8× 1.4k 1.7× 804 2.4× 165 0.6× 335 1.6× 46 2.3k
Menachem Moshkowitz Israel 21 524 0.6× 628 0.8× 606 1.8× 139 0.5× 92 0.4× 63 1.7k
Amanda Ricciuto Canada 17 1.7k 1.8× 1.3k 1.6× 849 2.5× 115 0.4× 282 1.3× 44 2.4k
A. Cassinotti Italy 24 1.2k 1.3× 987 1.2× 497 1.5× 67 0.3× 394 1.8× 59 2.0k
Kang‐Moon Lee South Korea 27 943 1.0× 837 1.0× 1.0k 3.1× 172 0.7× 347 1.6× 173 2.4k
Michael F. Picco United States 25 1.4k 1.5× 1.1k 1.3× 877 2.6× 131 0.5× 213 1.0× 142 2.2k

Countries citing papers authored by Nabeel Khan

Since Specialization
Citations

This map shows the geographic impact of Nabeel Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabeel Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabeel Khan more than expected).

Fields of papers citing papers by Nabeel Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabeel Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabeel Khan. The network helps show where Nabeel Khan may publish in the future.

Co-authorship network of co-authors of Nabeel Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Nabeel Khan. A scholar is included among the top collaborators of Nabeel Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabeel Khan. Nabeel Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Nabeel, et al.. (2025). Comparative Risk of Serious Infections Associated With Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 32(2). 199–206. 1 indexed citations
2.
Bahrain, Huzefa, et al.. (2023). Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia. Journal of Managed Care & Specialty Pharmacy. 29(7). 818–824. 1 indexed citations
3.
Gaur, Loveleen, et al.. (2023). Artificial intelligence for carbon emissions using system of systems theory. Ecological Informatics. 76. 102165–102165. 65 indexed citations
4.
Khan, Nabeel, et al.. (2023). Risk of severe and opportunistic infections and the impact of SARS‐COV‐2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 57(7). 800–807. 2 indexed citations
5.
Khan, Nabeel, et al.. (2023). DNS Tunnelling, Exfiltration and Detection over Cloud Environments. Sensors. 23(5). 2760–2760. 6 indexed citations
6.
Mahmud, Nadim, et al.. (2022). Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease. Clinical and Translational Gastroenterology. 14(4). e00554–e00554. 1 indexed citations
7.
Khan, Nabeel, et al.. (2021). The psychological impact of COVID-19 among the undergraduate dentistry students of Sindh and Baluchistan and how they manage it.. SHILAP Revista de lepidopterología. 26(1). 263–271. 1 indexed citations
8.
Khan, Nabeel, Nadim Mahmud, Chinmay Trivedi, Walter Reinisch, & James D. Lewis. (2021). Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System. Gut. 70(9). 1657–1664. 35 indexed citations
9.
10.
Khan, Nabeel, et al.. (2021). SARS-CoV-2-Associated Guillain-Barre Syndrome Obscured by Diabetes Mellitus Peripheral Neuropathy. Cureus. 13(3). e14209–e14209. 1 indexed citations
11.
Khan, Nabeel, et al.. (2021). Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 20(7). 1570–1578.e1. 20 indexed citations
12.
Patel, Dhruvan, Yu‐Xiao Yang, Chinmay Trivedi, et al.. (2019). Incidence, Duration, and Management of Anemia: A Nationwide Comparison Between IBD and Non-IBD Populations. Inflammatory Bowel Diseases. 26(6). 934–940. 11 indexed citations
13.
Khan, Nabeel, Helen Lee, Chinmay Trivedi, et al.. (2019). Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Diseases Receiving Treatment With Thiopurines. Clinical Gastroenterology and Hepatology. 17(11). 2262–2268. 4 indexed citations
14.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P565. The Increased Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients is not Related To Inflammatory Load. Journal of Crohn s and Colitis. 9(suppl 1). S363–S363. 3 indexed citations
15.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P566. Efficacy and safety of vedolizumab with advancing age in patients with ulcerative colitis: Results from the GEMINI 1 study. Journal of Crohn s and Colitis. 9(suppl 1). S363–S364. 1 indexed citations
16.
Khan, Nabeel, Hafiz Khan, & Faisal Mehmood. (2015). Optimal management of steroid-dependent ulcerative colitis. Clinical and Experimental Gastroenterology. 8. 293–293. 18 indexed citations
17.
Khan, Nabeel, et al.. (2013). Prevalence of Corticosteroids Use and Disease Course After Initial Steroid Exposure in Ulcerative Colitis. Digestive Diseases and Sciences. 58(10). 2963–2969. 30 indexed citations
18.
Khan, Nabeel, Ali Abbas, Martin Moehlen, & Luis A. Balart. (2013). Methotrexate in Ulcerative Colitis. Inflammatory Bowel Diseases. 19(7). 1379–1383. 17 indexed citations
19.
Adil, Muhammad, et al.. (2012). The trends of tobacco use among medical and non medical students in District Bannu. SHILAP Revista de lepidopterología.
20.
Khan, Nabeel & Jennifer Couper. (1996). Diurnal Variation of Blood Pressure in Adolescents with Type 1 Diabetes: Dippers and Non-dippers. Diabetic Medicine. 13(6). 531–535. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Kirchgesner Breakdown of academic impact, for papers by Amar R. Deshpande Breakdown of academic impact, for papers by Frank I. Scott Breakdown of academic impact, for papers by Susana Lopes Breakdown of academic impact, for papers by Ida Vind Breakdown of academic impact, for papers by Menachem Moshkowitz Breakdown of academic impact, for papers by Amanda Ricciuto Breakdown of academic impact, for papers by A. Cassinotti Breakdown of academic impact, for papers by Kang‐Moon Lee Breakdown of academic impact, for papers by Michael F. Picco
Rankless by CCL
2026